UnknownPhase 4NCT05626387
An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Studying Fibrotic hypersensitivity pneumonitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
- Principal Investigator
- Sahajal Dhooria, MD, DMPostgraduate Institute of Medical Education and Research, Chandigarh, India
- Intervention
- Mycophenolate Mofetil plus prednisolone(drug)
- Enrollment
- 144 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- Postgraduate Institute of Medical Education and Research, Chandigarh, India
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05626387 on ClinicalTrials.gov